<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="hsr270448" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Health Sci Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2398-8835</journal-id><journal-id journal-id-type="publisher-id">HSR2</journal-id><journal-title-group><journal-title>Health Science Reports</journal-title></journal-title-group><issn pub-type="epub">2398-8835</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39935845</article-id><article-id pub-id-type="pmc">PMC11810981</article-id>
<article-id pub-id-type="doi">10.1002/hsr2.70448</article-id><article-id pub-id-type="publisher-id">HSR270448</article-id><article-categories><subj-group subj-group-type="article-subject-classification"><subject>Allergy</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Gastroenterology/Hepatology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Immunology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>General Medicine</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Epidemiology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Obstetrics/Gynecology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Nutrition, Obesity and Exercise</subject></subj-group><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Goat Milk&#x02010;Based Infant Formula and the Prevalence of Gastrointestinal Symptoms in Infants: A Real&#x02010;World&#x02010;Evidence Study From Brazil, Mexico, Russia, and the Netherlands</article-title></title-group><contrib-group><contrib id="hsr270448-cr-0001" contrib-type="author" corresp="yes"><name><surname>Knipping</surname><given-names>Karen</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3700-9047</contrib-id><xref rid="hsr270448-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>karen.knipping@ausnutria.nl</email></address></contrib><contrib id="hsr270448-cr-0002" contrib-type="author"><name><surname>B&#x000f6;hme</surname><given-names>Juliane</given-names></name><xref rid="hsr270448-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hsr270448-cr-0003" contrib-type="author"><name><surname>Goossens</surname><given-names>Dominique</given-names></name><xref rid="hsr270448-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270448-cr-0004" contrib-type="author"><name><surname>van Lee</surname><given-names>Linde</given-names></name><xref rid="hsr270448-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270448-cr-0005" contrib-type="author"><name><surname>van der Zee</surname><given-names>Lucie</given-names></name><xref rid="hsr270448-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="hsr270448-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Ausnutria B.V.</institution>
<city>Zwolle</city>
<country country="NL">The Netherlands</country>
</aff><aff id="hsr270448-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Human Nutrition</named-content>
<institution>Wageningen University</institution>
<city>Wageningen</city>
<country country="NL">The Netherlands</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Karen Knipping (<email>karen.knipping@ausnutria.nl</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>8</volume><issue seq="71">2</issue><issue-id pub-id-type="doi">10.1002/hsr2.v8.2</issue-id><elocation-id>e70448</elocation-id><history>
<date date-type="rev-recd"><day>02</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>29</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>16</day><month>1</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Health Science Reports</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:HSR2-8-e70448.pdf"/><abstract><title>ABSTRACT</title><sec id="hsr270448-sec-0010"><title>Background and Aims</title><p>Infants often experience gastro&#x02010;intestinal (GI) symptoms whereby their nutrition might play a role in the occurrence of these symptoms. Evidence suggests that consuming goat milk&#x02010;based infant formula (GMF) may provide relief. Therefore, a study was performed to assess the prevalence of GI symptoms in infants and the role of GMF.</p></sec><sec id="hsr270448-sec-0020"><title>Methods</title><p>From June 2021 until November 2022, a cross&#x02010;sectional observational survey was conducted in Brazil, Mexico, Russia, and The Netherlands by recruiting parents/legal guardians through social media. GI symptoms after introduction of GMF were questioned using the validated Cow's Milk&#x02010;Related Symptom Score (CoMiSS; scoring 0&#x02013;33), lower scores indicate fewer symptoms. Occurrence of crying, gassiness, eczema, respiratory symptoms and stool consistency were asked retrospectively before and&#x02009;&#x02265;&#x02009;14 days after introduction of GMF.</p></sec><sec id="hsr270448-sec-0030"><title>Results</title><p>The study population (<italic toggle="yes">n</italic>&#x02009;=&#x02009;425) of GMF&#x02010;consumers mostly consisted of 0&#x02010;6 months&#x02010;old infants with a median age of 5 months. Overall, CoMiSS was low among GMF&#x02010;consumers (median 1.00, IQR 4.00, range 0&#x02013;14) of which 89% had CoMiSS&#x02009;&#x02264;&#x02009;6 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;317), indicating (severity of) symptoms commonly present in healthy infants. After introduction of GMF, the majority of infants had lower symptom scores of gassiness (87%, <italic toggle="yes">n</italic>&#x02009;=&#x02009;128), skin symptoms (78%, <italic toggle="yes">n</italic>&#x02009;=&#x02009;32), watery stools/diarrhea (80%, <italic toggle="yes">n</italic>&#x02009;=&#x02009;32) or hard stools/constipation (84%, <italic toggle="yes">n</italic>&#x02009;=&#x02009;57), and crying (87%, <italic toggle="yes">n</italic>&#x02009;=&#x02009;122). The CoMiSS in GMF&#x02010;consumers was significantly lower, meaning fewer symptoms, compared to GMF&#x02010;non&#x02010;consumers (<italic toggle="yes">p</italic>&#x02009;=&#x02009;&#x0003c;&#x02009;0.001). CoMiSS was similar among categories of age, sex, and country of residence.</p></sec><sec id="hsr270448-sec-0040"><title>Conclusion</title><p>This sample of infants fed GMF showed a low prevalence of GI symptoms and parents reported lower prevalence of GI symptoms after introduction of GMF based on retrospectively questionnaires. CoMiSS in GMF&#x02010;consumers was significantly lower when compared to GMF&#x02010;non&#x02010;consumers. These results give indications of a potential benefit of GMF in managing GI symptoms in infants. Clinicaltrial. gov identifier NCT06755424.</p></sec></abstract><kwd-group><kwd id="hsr270448-kwd-0001">consumer survey</kwd><kwd id="hsr270448-kwd-0002">cow's milk infant formula</kwd><kwd id="hsr270448-kwd-0003">CoMiSS</kwd><kwd id="hsr270448-kwd-0004">gastrointestinal symptoms</kwd><kwd id="hsr270448-kwd-0005">infantsgoat&#x02010;milk infant formula</kwd></kwd-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="9"/><word-count count="4939"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="hsr270448-note-0001"><p>These authors contributed equally to the manuscript</p></fn><fn id="hsr270448-note-0002"><p>All authors have read and approved the final version of the article, the corresponding author Karen Knipping had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.</p></fn></fn-group></notes></front><body><sec id="hsr270448-sec-0050"><label>1</label><title>Introduction</title><p>Adequate early life nutrition is essential for optimal health and growth of infants as well as for their health later in life [<xref rid="hsr270448-bib-0001" ref-type="bibr">1</xref>, <xref rid="hsr270448-bib-0002" ref-type="bibr">2</xref>]. Exclusive breastfeeding in the first 6 months of life is considered as the most optimal source of nutrition for infants. Despite the World Health Organization (WHO) recommendations, more than 50% of infants globally are not exclusively breastfed during their first 6 months of life, and are therefore dependent on infant formula for their nutrition from early infancy [<xref rid="hsr270448-bib-0003" ref-type="bibr">3</xref>]. Over the years, a variety of infant formulas have been developed; mostly based on cow's milk, whereas infant formula based on goat milk has been introduced in the last decades. The tolerability and nutritional adequacy of GMF has been previously examined in several studies, showing that GMF provides adequate nutrition for growth and is safe and suitable to use for infants [<xref rid="hsr270448-bib-0004" ref-type="bibr">4</xref>]. In 2012, the European Food Safety Authority (EFSA) stated that goat milk protein is suitable as a protein source in infant formulas [<xref rid="hsr270448-bib-0005" ref-type="bibr">5</xref>], in 2017 GRAS (generally recognized as safe) notification for nonfat dry goats' milk and goat whey protein concentrate in infant formula [<xref rid="hsr270448-bib-0006" ref-type="bibr">6</xref>] was granted by the Food and Drug Administration (FDA).</p><p>Gastrointestinal (GI) issues such as regurgitation, watery stools, constipation; skin issues like eczema and urticaria; respiratory issues such as wheezing; and general symptoms such as poor growth and infantile colic occur in 15%&#x02013;20% of infants [<xref rid="hsr270448-bib-0007" ref-type="bibr">7</xref>] and these symptoms can be related to cow's milk protein intake. The CoMiSS is a simple, fast and easy&#x02010;to&#x02010;use awareness tool for cow's milk&#x02010;related symptoms [<xref rid="hsr270448-bib-0008" ref-type="bibr">8</xref>]. CoMiSS&#x02009;&#x0003c;&#x02009;10 indicates symptoms possibly related to cow's milk protein intake, but not indicated as cow's milk allergy (CoMiSS&#x02009;&#x02265;&#x02009;10) [<xref rid="hsr270448-bib-0009" ref-type="bibr">9</xref>]. Goat milk based infant formula (GMF) may be a promising alternative for cow's milk based infant formula (CMF) for infants suffering from GI symptoms with CoMiSS&#x02009;&#x0003c;&#x02009;6.</p><p>Only limited research has been done to this date on GMF&#x02010;consumption and GI issues in infants. A case&#x02010;series study (<italic toggle="yes">n</italic>&#x02009;=&#x02009;20) examined the potential influence of GMF on symptoms of constipation in infants that were fed CMF before the introduction of GMF for 3 weeks. The authors found significantly softer stools (Bristol stool score 2 vs. 3, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) and less crying by the infants (3&#x02009;h/d vs. 1&#x02009;h/d; <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) [<xref rid="hsr270448-bib-0010" ref-type="bibr">10</xref>]. A prospective cohort study of 12 months by Han et al. concluded that stool consistency of infants fed CMF was harder than of GMF&#x02010;fed and breastfed infants (<italic toggle="yes">n</italic>&#x02009;=&#x02009;976). Furthermore, GMF fed infants' bowel motions tended to be similar to those of breastfed infants (&#x02009;&#x0003e;&#x02009;7/d; <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) while CMF&#x02010;fed infants had fewer bowel motions (mostly 1&#x02013;2/day) compared to breast&#x02010;fed infants [<xref rid="hsr270448-bib-0011" ref-type="bibr">11</xref>]. A randomized controlled trial (RCT) by Grant et al. showed that median daily bowel movement frequency was higher for GMF&#x02010;fed infants in comparison to CMF fed infants (2.4 vs 1.7, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.01) [<xref rid="hsr270448-bib-0012" ref-type="bibr">12</xref>]. In a case study (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3), the consumption of GMF for 3 weeks was well tolerated in 11&#x02010;month&#x02010;old infants who experienced symptoms related to cow's milk consumption, and CoMiSS reduced after the introduction of GMF [<xref rid="hsr270448-bib-0013" ref-type="bibr">13</xref>].</p><p>Due to the limited research, the potential impact of GMF consumption on GI symptoms in infants needs to be further investigated. Therefore, a cross&#x02010;sectional online&#x02010;survey was designed aiming to study the occurrence of GI symptoms and the possible role of GMF to relief GI symptoms.</p></sec><sec sec-type="methods" id="hsr270448-sec-0060"><label>2</label><title>Methods</title><sec id="hsr270448-sec-0070"><label>2.1</label><title>Study Design and Population</title><p>A cross&#x02010;sectional observational online anonymous survey on GI symptoms in infants aged 0&#x02013;24 months fed GMF has been developed and conducted in Brazil, Mexico, Russia, and The Netherlands. The GMF of interest was commercially available Kabrita stage 1 or 2 (Ausnutria, B.V., the Netherlands). Participants who had purchased Kabrita were asked to complete a voluntary survey regarding their experience and observation on their infant's GI complaints. No inclusion criteria were set at the time point of sending out the survey. The survey consisted of 30 questions and was online from June 2021 until November 2022. The study was registered with the US Library of Medicine (clinicaltrials. gov) with identifier NCT06755424.</p></sec><sec id="hsr270448-sec-0080"><label>2.2</label><title>Human Ethics and Consent to Participate Declarations</title><p>The survey and associated data collection do not meet the criteria for human subject research and therefore approval by an institutional and/or licensing committee is not needed, and participant consent is not required. Participation in the survey was anonymized and completely voluntary.</p></sec><sec id="hsr270448-sec-0090"><label>2.3</label><title>Study Outcomes</title><p>The primary outcome of this study were GI symptoms as assessed by the Cow's Milk&#x02010;Related Symptom Score (CoMiSS) after introduction of GMF. The CoMiSS was developed by an expert panel to increase the awareness of health care professionals for the presence and severity of symptoms, which might be related to cow's milk protein intake [<xref rid="hsr270448-bib-0008" ref-type="bibr">8</xref>]. The CoMiSS is a validated and easy&#x02010;to&#x02010;use clinical tool with an estimated sensitivity between 20% and 77% and a specificity of 54%&#x02013;92% to suspected cow's milk allergy [<xref rid="hsr270448-bib-0009" ref-type="bibr">9</xref>]. The CoMiSS assesses the stool pattern using the Bristol Scale (hard stools, normal stools, soft stools, liquid stools, watery stools); skin symptoms of atopic eczema on head, neck and/or trunk as well as on arms, hands and/or feet; skin symptoms of urticaria; respiratory symptoms, regurgitation; and crying without any obvious cause in hours per day. The total score ranges from 0 to 33, where lower scores indicate less severe symptoms [<xref rid="hsr270448-bib-0007" ref-type="bibr">7</xref>]. The exact sub&#x02010;categories of the CoMiSS per symptom can be found in Table&#x000a0;<xref rid="hsr270448-tbl-0003" ref-type="table">3</xref>. As a secondary study outcome, the survey inquired retrospectively about GI symptoms before introduction of Kabrita and whether these symptoms improved minimally 14 days after introduction. These symptoms included gassiness (specified as burping, passing gas, bloating, abdominal pain and/or colic); skin symptoms (specified as rashes, and/or presence of eczema); watery stools or diarrhea; hard stools or constipation; and crying without any obvious cause.</p></sec><sec id="hsr270448-sec-0100"><label>2.4</label><title>Exposure</title><p>Kabrita fulfils the national requirements for infant formulas. The exact compositions of Kabrita differ slightly between countries, according to national criteria. The kcal content per 100&#x02009;ml (13.2&#x02013;13.5&#x02009;g powder&#x02009;+&#x02009;90&#x02009;ml water) ranges from 66 to 68&#x02009;kcal, protein from 1.3 to 1.7&#x02009;g, carbohydrates from 7.3 to 8.2&#x02009;g, and total fat from 3.4 to 3.5&#x02009;g. Vitamin and mineral contents are similar among countries.</p><p>The main exposure of interest was the proportion of fed GMF of the infants' total feed (exclusively 100%, predominantly&#x02009;&#x0003e;&#x02009;60%, often 10%&#x02013;60%, occasionally&#x02009;&#x0003c;&#x02009;10%). Additionally, the infants' consumption of GMF per day in ml was monitored. The amount was calculated by multiplying the consumed number of bottles per day by the consumed volume per bottle.</p></sec><sec id="hsr270448-sec-0110"><label>2.5</label><title>Covariates</title><p>Infant characteristics, that is, age in months, sex (girl, boy, unknown), birthweight (&#x02009;&#x0003c;&#x02009;2500&#x02009;g, 2500&#x02013;4500&#x02009;g,&#x02009;&#x0003e;&#x02009;4500&#x02009;g), being term (gestational age 37&#x02013;42 weeks), country of residence (Brazil, Mexico, Russia, The Netherlands), previous feeding regime (CMF, another GMF than Kabrita, a formula based on soy, breastmilk or &#x0201c;other&#x0201d;), the infants age when Kabrita was introduced, parent's perception of a generally healthy status of their infant (y/n), use of any medication for functional GI disorders (y/n), and household smoking (inside the house, outside the house, no smoking) were assessed by the survey.</p></sec><sec id="hsr270448-sec-0120"><label>2.6</label><title>Statistical Analyses</title><p>Exclusion criteria for the study population were age&#x02009;&#x0003e;&#x02009;24 months and taking medication for functional GI disorders. Of the infants meeting the inclusion criteria, the infants regularly consuming Kabrita (&#x02009;&#x0003e;&#x02009;10%) for&#x02009;&#x0003e;&#x02009;14 consecutive days were assigned to the GMF&#x02010;consumer group. The infants who were only occasionally or not fed with Kabrita (&#x02009;&#x0003c;&#x02009;10%) or fed&#x02009;&#x0003c;&#x02009;14 consecutive days with Kabrita were included in the GMF&#x02010;non&#x02010;consumers group, and analyses were done to compare the CoMiSS of the GMF&#x02010;consumers with the CoMiSS of the GMF&#x02010;non&#x02010;consumers. Tests for normality (QQ plots) were performed. Descriptives were performed to present the characteristics among GMF&#x02010;consumers and GMF&#x02010;non&#x02010;consumers as medians with interquartile range (IQR) for skewed variables and <italic toggle="yes">n</italic> (%) for categorical variables.</p><p>Differences of the CoMiSS (dependent variable) between sex and country of residence categories (independent variables) were explored using the Independent&#x02010;Samples Median Test to estimate potential differences in median CoMiSS. To test for differences in median CoMiSS across age, Poisson regression was performed while correcting for smoking in household. To compare overall median CoMiSS as well as per sub&#x02010;categories between GMF&#x02010;consumers versus GMF&#x02010;non&#x02010;consumers, Poisson regression while correcting for smoking in household, age, sex, and country of residence, and Chi&#x02010;Square Test for dichotomous variables were performed. The data was analyzed using IBM SPSS Statistics 29. A <italic toggle="yes">p</italic>&#x02010;value of&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="hsr270448-sec-0130"><label>3</label><title>Results</title><sec id="hsr270448-sec-0140"><label>3.1</label><title>Study Population's Characteristics</title><p>In total, 595 responses were collected (146 in Brazil, 135 in Mexico, 304 in Russia, 10 in The Netherlands), of which 425 were included for analysis (Figure&#x000a0;<xref rid="hsr270448-fig-0001" ref-type="fig">1</xref>). The study population of GMF&#x02010;consumers mostly consisted of 0&#x02013;6 months&#x02010;old infants (61%) with a median age of 5 months (Table&#x000a0;<xref rid="hsr270448-tbl-0001" ref-type="table">1</xref>). Sex was almost equally distributed (44% girls, 53% boys, 3% unknown). Half of the GMF&#x02010;consumers resided in Russia, 28% in Mexico, 20% in Brazil and 2% in The Netherlands. Most infants had a birth weight between 2500 and 4500&#x02009;g (91%), were term infants (83%) and were considered &#x0201c;generally healthy&#x0201d; (86%). In most of the infant's households nobody smoked (69%).</p><fig position="float" fig-type="Figure" id="hsr270448-fig-0001"><label>Figure 1</label><caption><p>Flowchart of participants.</p></caption><graphic xlink:href="HSR2-8-e70448-g002" position="anchor" id="jats-graphic-1"/></fig><table-wrap position="float" id="hsr270448-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>Characteristics of GMF&#x02010;consumers (<italic toggle="yes">n</italic>&#x02009;=&#x02009;356) and GMF&#x02010;non&#x02010;consumers (<italic toggle="yes">n</italic>&#x02013;69).</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">GMF&#x02010;consumers</th><th align="center" valign="bottom" rowspan="1" colspan="1">GMF&#x02010;non&#x02010;consumers</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%) or mean (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%) or mean (SD)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">0<italic toggle="yes">&#x02013;</italic>6 months</td><td align="center" valign="top" rowspan="1" colspan="1">217 (61)</td><td align="center" valign="top" rowspan="1" colspan="1">36 (52)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">7<italic toggle="yes">&#x02013;</italic>12 months</td><td align="center" valign="top" rowspan="1" colspan="1">82 (23)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (30)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">13&#x02013;24 months</td><td align="center" valign="top" rowspan="1" colspan="1">57 (16)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (17)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">156 (44)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (49)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">190 (53)</td><td align="center" valign="top" rowspan="1" colspan="1">35 (51)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">10 (3)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Country of residence</td><td align="center" valign="top" rowspan="1" colspan="1">Brazil</td><td align="center" valign="top" rowspan="1" colspan="1">72 (20)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (28)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Mexico</td><td align="center" valign="top" rowspan="1" colspan="1">101 (28)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Russia</td><td align="center" valign="top" rowspan="1" colspan="1">177 (50)</td><td align="center" valign="top" rowspan="1" colspan="1">46 (67)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">The Netherlands</td><td align="center" valign="top" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Birthweight</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;2500&#x02009;g</td><td align="center" valign="top" rowspan="1" colspan="1">24 (7)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2500&#x02013;4500&#x02009;g</td><td align="center" valign="top" rowspan="1" colspan="1">324 (91)</td><td align="center" valign="top" rowspan="1" colspan="1">65 (94)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;&#x02009;4500&#x02009;g</td><td align="center" valign="top" rowspan="1" colspan="1">8 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Term infant</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">295 (83)</td><td align="center" valign="top" rowspan="1" colspan="1">59 (86)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Perceived as generally healthy</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">307 (86)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (70)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Someone smoking in household</td><td align="center" valign="top" rowspan="1" colspan="1">Inside the house</td><td align="center" valign="top" rowspan="1" colspan="1">21 (6)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Outside the house</td><td align="center" valign="top" rowspan="1" colspan="1">90 (25)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (30)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">245 (69)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (63)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Proportion of GMF of total food</td><td align="center" valign="top" rowspan="1" colspan="1">Exclusively (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">206 (58)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Predominantly (&#x0003e;&#x02009;60%)</td><td align="center" valign="top" rowspan="1" colspan="1">78 (22)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Often (10%&#x02013;60%)</td><td align="center" valign="top" rowspan="1" colspan="1">72 (22)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Occasionally (&#x0003c;&#x02009;10%)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="top" rowspan="1" colspan="1">22 (32)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">No (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="top" rowspan="1" colspan="1">47 (68)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Consumption of GMF/d (ml)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">675 (SD 357)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Previous feeding regime</td><td align="center" valign="top" rowspan="1" colspan="1">Human milk</td><td align="center" valign="top" rowspan="1" colspan="1">190 (53)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">CMF</td><td align="center" valign="top" rowspan="1" colspan="1">115 (32)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">GMF other than Kabrita</td><td align="center" valign="top" rowspan="1" colspan="1">16 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Soy&#x02010;based formula</td><td align="center" valign="top" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Other</td><td align="center" valign="top" rowspan="1" colspan="1">29 (8)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age when switched to Kabrita</td><td align="center" valign="top" rowspan="1" colspan="1">Between 0&#x02013;6 months</td><td align="center" valign="top" rowspan="1" colspan="1">291 (82)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Between 6&#x02013;12 months</td><td align="center" valign="top" rowspan="1" colspan="1">50 (14)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;&#x02009;12 months</td><td align="center" valign="top" rowspan="1" colspan="1">15 (4)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CoMiSS</td><td align="center" valign="top" rowspan="1" colspan="1">Median</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">IQR</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Range</td><td align="center" valign="top" rowspan="1" colspan="1">0&#x02013;14</td><td align="center" valign="top" rowspan="1" colspan="1">0&#x02013;13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Score&#x02009;&#x0003c;&#x02009;6</td><td align="center" valign="top" rowspan="1" colspan="1">317 (89)</td><td align="center" valign="top" rowspan="1" colspan="1">54 (78)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>The majority of GMF&#x02010;consumers was fed &#x0201c;exclusively with GMF&#x0201d; (58%), 22% &#x0201c;predominantly&#x0201d; and 20% &#x0201c;often.&#x0201d; The mean (SD) consumption of GMF per day was 675&#x02009;ml (357.28). Most GMF&#x02010;consumers were 0&#x02010;6 months old (82%) when GMF was introduced to their diet and were fed human milk before (53.2%), a third of the GMF&#x02010;consumers (32.4%) switched from CMF to Kabrita, 4.5% from another GMF than Kabrita, 1.7% from a soy&#x02010;based formula and 8.2% switched from &#x0201c;other&#x0201d; to Kabrita.</p></sec><sec id="hsr270448-sec-0150"><label>3.2</label><title>GI Symptoms Before and After Introduction of Kabrita</title><p>Among GMF&#x02010;consumers, the most common reported complaint in infants before the introduction of GMF was gassiness (41%), followed by crying without any obvious cause (39%), and hard stools or constipation (19%). Skin symptoms (12%), and watery stools or diarrhea (11%) were the least often reported symptoms before introduction. Most parents (76%) reported that their infant experienced, in general, fewer complaints after introduction of GMF. For the specific GI symptoms, 87% of infants who experienced gassiness before the introduction of GMF, did not report gassiness after introduction. For skin symptoms, 78% lower frequency of reporting skin symptoms after introduction, for watery stools or diarrhea 80%, and for hard stools or constipation 84% after introduction. Crying without any obvious cause was lower after introduction of GMF for 87% of infants (Figure&#x000a0;<xref rid="hsr270448-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="Figure" id="hsr270448-fig-0002"><label>Figure 2</label><caption><p>Number of infants with symptoms before and after introduction of GMF among GMF&#x02010;consumers (<italic toggle="yes">n</italic>&#x02009;=&#x02009;356).</p></caption><graphic xlink:href="HSR2-8-e70448-g001" position="anchor" id="jats-graphic-3"/></fig><p>The highest prevalence of minor complaints before introduction of Kabrita was reported in former CMF&#x02010;fed infants (87%), followed by other GMF (56%), soy&#x02010;based formula (50%), and &#x0201c;other&#x0201d; (45%). Former breastfed infants showed the lowest prevalence (44%) of minor complaints in general before introduction of GMF (Table&#x000a0;<xref rid="hsr270448-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="hsr270448-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Previous feeding regime and prevalence of GI symptoms before introduction of Kabrita (<italic toggle="yes">n</italic>&#x02009;=&#x02009;356).</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Previous feeding regime</th><th align="center" valign="bottom" rowspan="1" colspan="1">Minor complaints in general</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gassiness</th><th align="center" valign="bottom" rowspan="1" colspan="1">Skin symptoms</th><th align="center" valign="bottom" rowspan="1" colspan="1">Watery stools or diarrhea</th><th align="center" valign="bottom" rowspan="1" colspan="1">Hard stools or constipation</th><th align="center" valign="bottom" rowspan="1" colspan="1">Crying without any obvious cause</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Breastfeeding (<italic toggle="yes">n</italic>&#x02009;=&#x02009;190)</td><td align="center" valign="top" rowspan="1" colspan="1">44.2%</td><td align="center" valign="top" rowspan="1" colspan="1">56.0%</td><td align="center" valign="top" rowspan="1" colspan="1">13.1%</td><td align="center" valign="top" rowspan="1" colspan="1">16.7%</td><td align="center" valign="top" rowspan="1" colspan="1">22.6%</td><td align="center" valign="top" rowspan="1" colspan="1">33.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CMF (<italic toggle="yes">n</italic>&#x02009;=&#x02009;114)</td><td align="center" valign="top" rowspan="1" colspan="1">86.8%</td><td align="center" valign="top" rowspan="1" colspan="1">64.6%</td><td align="center" valign="top" rowspan="1" colspan="1">24.2%</td><td align="center" valign="top" rowspan="1" colspan="1">23.2%</td><td align="center" valign="top" rowspan="1" colspan="1">37.4%</td><td align="center" valign="top" rowspan="1" colspan="1">53.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GMF other than Kabrita (<italic toggle="yes">n</italic>&#x02009;=&#x02009;16)</td><td align="center" valign="top" rowspan="1" colspan="1">56.3%</td><td align="center" valign="top" rowspan="1" colspan="1">55.6%</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">44.4%</td><td align="center" valign="top" rowspan="1" colspan="1">37.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Soy&#x02010;based formula (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6)</td><td align="center" valign="top" rowspan="1" colspan="1">50.0%</td><td align="center" valign="top" rowspan="1" colspan="1">33.3%</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">33.3%</td><td align="center" valign="top" rowspan="1" colspan="1">16.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Other (<italic toggle="yes">n</italic>&#x02009;=&#x02009;29)</td><td align="center" valign="top" rowspan="1" colspan="1">44.8%</td><td align="center" valign="top" rowspan="1" colspan="1">81.3%</td><td align="center" valign="top" rowspan="1" colspan="1">18.8%</td><td align="center" valign="top" rowspan="1" colspan="1">12.5%</td><td align="center" valign="top" rowspan="1" colspan="1">25.0%</td><td align="center" valign="top" rowspan="1" colspan="1">24.1%</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="hsr270448-sec-0160"><label>3.3</label><title>CoMISS Among Study Population</title><p>The overall CoMiSS among GMF&#x02010;consumers was low (median 1.00, IQR 4.00, range 0&#x02013;14) (Table&#x000a0;<xref rid="hsr270448-tbl-0001" ref-type="table">1</xref>). Almost all GMF&#x02010;consumers showed a CoMiSS&#x02009;&#x02264;&#x02009;6 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;317, 89%), indicating symptoms commonly present in healthy infants.</p><p>The GMF&#x02010;non&#x02010;consumers showed a higher CoMiSS (median 2.00, IQR 6.00, range 0&#x02013;13) and 78% (<italic toggle="yes">n</italic>&#x02009;=&#x02009;54) had a CoMiSS&#x02009;&#x02264;&#x02009;6 than the GMF&#x02010;consumers (Table&#x000a0;<xref rid="hsr270448-tbl-0001" ref-type="table">1</xref>). Poisson regression showed that GMF&#x02010;consumers had a 0.52 points significantly lower CoMiSS than GMF&#x02010;non&#x02010;consumers while corrected for smoking in household, age, sex, and country (<italic toggle="yes">p</italic>&#x02009;=&#x02009;&#x0003c;&#x02009;0.001) (data not shown).</p><p>The subscore crying without any obvious cause was significantly lower for GMF&#x02010;consumers compared to GMF&#x02010;non&#x02010;consumers (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.003) as well as for stool consistency (<italic toggle="yes">p</italic>&#x02009;=&#x02009;&#x0003c;&#x02009;0.001), and urticaria (median test <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.001). The remaining categories (regurgitation, eczema, respiratory symptoms) did not show significant differences in CoMiSS between GMF&#x02010;consumers and GMF&#x02010;non&#x02010;consumers (Table&#x000a0;<xref rid="hsr270448-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="hsr270448-tbl-0003" content-type="Table"><label>Table 3</label><caption><p>Median (IQR, gray lines) or <italic toggle="yes">n</italic> (%) per symptom contributing to the CoMiSS among GMF&#x02010;consumers (<italic toggle="yes">n</italic>&#x02009;=&#x02009;356) and GMF&#x02010;non&#x02010;consumers (<italic toggle="yes">n</italic>&#x02009;=&#x02009;69).</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">GMF&#x02010;consumers</th><th align="center" valign="bottom" rowspan="1" colspan="1">GMF&#x02010;non&#x02010;consumers</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall CoMiSS</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (4.00)</td><td align="center" valign="top" rowspan="1" colspan="1">2.00 (6.00)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Crying without any obvious cause</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;1&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">301 (85)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (80)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1&#x02013;1.5&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">36 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (10)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1.5&#x02013;2&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">11 (3)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (4)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2&#x02013;3&#x02009;h/day</td><td align="center" valign="top" rowspan="1" colspan="1">3 (1)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">3&#x02013;4&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">4&#x02013;5&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x0003e;&#x02009;5&#x02009;h/d</td><td align="center" valign="top" rowspan="1" colspan="1">3 (1)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Regurgitation</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.72</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">0&#x02013;2 episodes/d</td><td align="center" valign="top" rowspan="1" colspan="1">286 (80)</td><td align="center" valign="top" rowspan="1" colspan="1">57 (83)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">3&#x02013;5 small volume</td><td align="center" valign="top" rowspan="1" colspan="1">43 (12)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (7)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x0003e;&#x02009;5 episodes of&#x02009;&#x0003e;&#x02009;1 coffee spoon</td><td align="center" valign="top" rowspan="1" colspan="1">17 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (4)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x0003e;&#x02009;5 episodes of&#x02009;+&#x02009;half of the feed in&#x02009;&#x0003c;&#x02009;half of the feeds</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (3)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Continuous regurgitation of small volumes&#x02009;&#x0003e;&#x02009;30&#x02009;min after each feed</td><td align="center" valign="top" rowspan="1" colspan="1">8 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (3)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Regurgitation of the complete feed after each feeding</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stool consistency</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (2.00)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Hard stool (type I)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (8)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (13)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Normal stools (type 2 or type 3)</td><td align="center" valign="top" rowspan="1" colspan="1">286 (80)</td><td align="center" valign="top" rowspan="1" colspan="1">57 (83)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Soft stools (type 4)</td><td align="center" valign="top" rowspan="1" colspan="1">29 (8)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (15)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Liquid stools (type 5A)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (3)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (10)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Watery stools (type 5B)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Urticaria</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (3.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.001<xref rid="hsr270448-tbl3-note-0001" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Present</td><td align="center" valign="top" rowspan="1" colspan="1">37 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">17 (25)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Absent</td><td align="center" valign="top" rowspan="1" colspan="1">319 (90)</td><td align="center" valign="top" rowspan="1" colspan="1">52 (75)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eczema</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Absent (less than 1/3 of head, neck and/or trunk)</td><td align="center" valign="top" rowspan="1" colspan="1">318 (89)</td><td align="center" valign="top" rowspan="1" colspan="1">66 (96)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mild (1/3&#x02013;2/3 of head, neck and/or trunk)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (8)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Moderate (over 2/3 of head, neck and/or trunk)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (3)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Severe (head, neck and/or trunk fully covered with eczema)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Respiratory symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Absent</td><td align="center" valign="top" rowspan="1" colspan="1">320 (90)</td><td align="center" valign="top" rowspan="1" colspan="1">60 (87)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mild</td><td align="center" valign="top" rowspan="1" colspan="1">30 (8)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (12)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Moderate</td><td align="center" valign="top" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="hsr270448-tbl3-note-0001"><label>*</label><p>Chi&#x02010;Square test for dichotomous variable was performed, <italic toggle="yes">p</italic>&#x02010;values adjusted for smoking in household, age, sex, and country of residence.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec sec-type="discussion" id="hsr270448-sec-0170"><label>4</label><title>Discussion</title><p>The results of our study on parent&#x02010;reported GI symptoms in infants consuming GMF showed an overall low CoMiSS, indicating severity of symptoms commonly present in healthy infants. For most infants experiencing GI symptoms before introducing GMF, the severity of symptoms was lower after introduction. Analyses demonstrated that the CoMiSS was significantly lower, meaning fewer symptoms, in GMF&#x02010;consumers compared to GMF&#x02010;non&#x02010;consumers.</p><p>Our findings in infants consuming GMF showing an overall low score on crying in hours per day (85% cried&#x02009;&#x0003c;&#x02009;1&#x02009;h/d) as well as a high proportion of infants with normal stools (80%), are similar to the findings of Infante et al. (2018). This study showed improvement of GI symptoms in infants after introducing GMF for 3 weeks: better stool consistency (from harder to softer stool) and less crying (from 3&#x02009;h/24&#x02009;h to 1&#x02009;h/24&#x02009;h) [<xref rid="hsr270448-bib-0010" ref-type="bibr">10</xref>]. Han et al. showed a similar finding by concluding that CMF fed infants had harder stools and less frequent bowel motions in than GMF fed infants [<xref rid="hsr270448-bib-0011" ref-type="bibr">11</xref>]. Moreover, our finding on lower GI symptoms after the introduction of GMF is in alignment with the study by Salsberg et al., who found a reduction in cow&#x02010;milk related symptoms after the introduction of GMF [<xref rid="hsr270448-bib-0013" ref-type="bibr">13</xref>]. Due to our study design, drawing conclusions about causality between GMF&#x02010;consumption and GI symptoms is not possible. Nevertheless, the results might suggest that there is a benefit of GMF&#x02010;consumption in healthy infants.</p><p>Literature on suitability of GMF for infants show adequate growth, acceptable GI tolerance and safety outcomes. GI tolerability was assessed either by mean number of stool motions/day [<xref rid="hsr270448-bib-0014" ref-type="bibr">14</xref>], frequency of adverse events such as vomiting, diarrhea, constipation or food refusal [<xref rid="hsr270448-bib-0012" ref-type="bibr">12</xref>] or risk of an adverse health condition, including GI illness and reflux [<xref rid="hsr270448-bib-0015" ref-type="bibr">15</xref>]. None of these studies showed a differences between GMF and CMF in GI tolerability. In a case series study in infants (<italic toggle="yes">n</italic>&#x02009;=&#x02009;20) an improvement of stool characteristics and reduction in crying was seen, however, GI symptoms were not scored in this study [<xref rid="hsr270448-bib-0010" ref-type="bibr">10</xref>]. Our survey results does show a significant lower CoMiSS in GMF&#x02010;consumers when compared to GMF&#x02010;non&#x02010;consumers. Future randomized controlled studies should investigate whether CoMiSS might be a better tool to assess GI tolerability in infants consuming GMF and CMF.</p><p>Due to the different compositions of Kabrita between countries, it would have been possible that the CoMiSS was different between countries. The prebiotics (GOS and FOS), for example, not present in Kabrita Brazil, are known for their effect on softer stools and an increased stool frequency [<xref rid="hsr270448-bib-0016" ref-type="bibr">16</xref>]. <italic toggle="yes">Bifidobacterium animalis subsp. lactis</italic>, BB&#x02010;12, only present in Kabrita Russia, has been associated with less crying in infants [<xref rid="hsr270448-bib-0017" ref-type="bibr">17</xref>]. However, no significant difference in the CoMiSS between countries (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.45) was observed, which might be due to the use of questionnaires not being sensitive enough to detect these differences and should be studied in randomized controlled studies.</p><sec id="hsr270448-sec-0180"><label>4.1</label><title>Potential Mechanisms</title><p>The biological mechanism through which GMF might have a beneficial effect on GI symptoms could be its protein digestion. It has been previously shown that the initial protein digestion of GMF is faster than the digestion of CMF, while their protein quality is similar [<xref rid="hsr270448-bib-0018" ref-type="bibr">18</xref>]. In comparison to CMF, GMF forms under gastric conditions smaller flocs of aggregated protein and smaller oil droplets. These may explain the faster gastric emptying since smaller and softer curds can promote digestive activity of the gastric proteases, while larger particles will not easily pass the gastric tract since they need to be broken down by pepsin before emptying is possible [<xref rid="hsr270448-bib-0019" ref-type="bibr">19</xref>, <xref rid="hsr270448-bib-0020" ref-type="bibr">20</xref>]. The coagulation and the size of oil droplets may depend on the protein composition, which differs between GM, CM and human milk (HM). In contrast to CM, GM shows a lower casein content and a different protein profile/composition. GM contains less &#x003b1;&#x02010;s1&#x02010;casein, has a larger &#x003b2;&#x02010;casein proportion and a larger casein micelle size than CM [<xref rid="hsr270448-bib-0019" ref-type="bibr">19</xref>]. In HM, &#x003b2;&#x02010;casein is the major protein while &#x003b1;&#x02010;s1&#x02010;casein is not present. The digestion kinetics of GMF are more comparable to HM than those of CMF [<xref rid="hsr270448-bib-0020" ref-type="bibr">20</xref>], which is to consider positively in view of HM being the gold standard in infant nutrition [<xref rid="hsr270448-bib-0021" ref-type="bibr">21</xref>]. However, the clinical relevance of the faster digestion of GMF compared to CMF on GI symptoms in infants is yet ambiguous. Previous research only refers to the protein physicochemical properties and kinetics of GM and not of GMF and its digestion and influence on GI symptoms in infants.</p></sec><sec id="hsr270448-sec-0190"><label>4.2</label><title>Limitations</title><p>The present study has the following limitations. The research was done using a cross&#x02010;sectional survey design, where data was collected at a single time&#x02010;point, which does not allow conclusions about causality. Since this was an observational study, the survey has been sent out to parents who were already been purchasing Kabrita. Although we were able to correct for the confounding factors age, sex, country of residence and smoking, other possible confounding factors such as education and socioeconomic status were not recorded but could have an impact the results obtained here [<xref rid="hsr270448-bib-0022" ref-type="bibr">22</xref>]. Including these factors in analysis might have led to higher quality of effect estimates and less residual confounding. Furthermore, measurement errors may have occurred due to subjective answers, as the survey was distributed among parents already feeding Kabrita to their child. Therefore, most participants' perception of Kabrita might have been positive because they believe it is beneficial or already had positive experiences, which could have contributed to the positive results regarding GMF consumption. The retrospective observational set&#x02010;up might have led to recall bias (participants had to answer the questions about GI symptoms before introduction of Kabrita retrospectively).</p></sec><sec id="hsr270448-sec-0200"><label>4.3</label><title>Strengths</title><p>The present study contains the following strengths. This study is the first online survey focused on GMF introduction, performed in four countries representing Europe and South&#x02010;America providing real&#x02010;world evidence. Furthermore, the CoMiSS used in this study is a validated tool. Vandenplas et al. concluded that the use of the CoMiSS by parents without additional training to assess GI symptoms of their infant results in a reliable score [<xref rid="hsr270448-bib-0023" ref-type="bibr">23</xref>].</p></sec><sec id="hsr270448-sec-0210"><label>4.4</label><title>Conclusion and Future Studies</title><p>In conclusion, this study of healthy infants showed a low prevalence of GI symptoms and parents reported lower prevalence of GI symptoms after introduction of GMF. CoMiSS in GMF&#x02010;consumers was significantly lower when compared to consumers of other infant formulas. This real&#x02010;world&#x02010;evidence research gives indication that GMF might be a valuable alternative for infants suffering from mild GI complaints. This could help healthcare professionals such as pediatricians, pediatric nurses and midwifes to recommend GMF such as Kabrita in infants with mild GI symptoms when breastfeeding is not possible. A follow&#x02010;up, well&#x02010;powered, double&#x02010;blinded study with a standardized CMF control product is needed to confirm the beneficial outcomes in GI symptoms when using GMF.</p></sec></sec><sec id="hsr270448-sec-0220"><title>Author Contributions</title><p>
<bold>Karen Knipping:</bold> formal analysis, investigation, methodology. <bold>Juliane B&#x000f6;hme:</bold> data curation, formal analysis, investigation, methodology. <bold>Dominique Goossens:</bold> conceptualization, formal analysis, project administration. <bold>Linde Lee:</bold> conceptualization, formal analysis, project administration. <bold>Lucie Zee:</bold> conceptualization, formal analysis, project administration.</p></sec><sec sec-type="COI-statement" id="hsr270448-sec-0230"><title>Conflicts of Interest</title><p>The study was funded by Ausnutria B.V. Karen Knipping, Dominique Goossens, Linde van Lee and Lucie van der Zee are employee of Ausnutria B.B and were involved in study design; collection, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication. Juliane B&#x000f6;hme declare no conflict if interest.</p></sec><sec id="hsr270448-sec-0240"><sec disp-level="2" id="hsr270448-sec-0260"><title>Transparency statement</title><p>The corresponding Karen Knipping affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.</p></sec></sec></body><back><sec sec-type="data-availability" id="hsr270448-sec-0250"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="hsr270448-bibl-0001"><title>References</title><ref id="hsr270448-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="hsr270448-cit-0001">WHO, <italic toggle="yes">Exclusive Breastfeeding for Six Months Best for Babies Every Where</italic> (<year>2011</year>), <ext-link xlink:href="https://www.who.int/news/item/15-01-2011-exclusive-breastfeeding-for-six-months-best-for-babies-everywhere#:~:text=WHO%20recommends%20mothers%20worldwide%20to" ext-link-type="uri">https://www.who.int/news/item/15-01-2011-exclusive-breastfeeding-for-six-months-best-for-babies-everywhere#:~:text=WHO%20recommends%20mothers%20worldwide%20to</ext-link>.</mixed-citation></ref><ref id="hsr270448-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="hsr270448-cit-0002">
<string-name>
<given-names>B.</given-names>
<surname>Koletzko</surname>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Godfrey</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Poston</surname>
</string-name>, et al., &#x0201c;<article-title>Nutrition During Pregnancy, Lactation and Early Childhood and Its Implications for Maternal and Long&#x02010;Term Child Health: The Early Nutrition Project Recommendations</article-title>,&#x0201d; <source>Annals of Nutrition and Metabolism</source>
<volume>74</volume>, no. <issue>2</issue> (<year>2019</year>): <fpage>93</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">30673669</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hsr270448-cit-0003">
<string-name>
<given-names>J. Y.</given-names>
<surname>Meek</surname>
</string-name> and <string-name>
<given-names>L.</given-names>
<surname>Noble</surname>
</string-name>, &#x0201c;<article-title>Policy Statement: Breastfeeding and the Use of Human Milk</article-title>,&#x0201d; <source>Pediatrics</source>
<volume>150</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>e2022057988</elocation-id>.<pub-id pub-id-type="pmid">35921640</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hsr270448-cit-0004">
<string-name>
<given-names>M.</given-names>
<surname>Jankiewicz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>van Lee</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Biesheuvel</surname>
</string-name>, <string-name>
<given-names>E. M.</given-names>
<surname>Brouwer&#x02010;Brolsma</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>van der Zee</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Szajewska</surname>
</string-name>, &#x0201c;<article-title>The Effect of Goat&#x02010;Milk&#x02010;Based Infant Formulas on Growth and Safety Parameters: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Nutrients</source>
<volume>15</volume>, no. <issue>9</issue> (<year>2023</year>): <fpage>2110</fpage>.<pub-id pub-id-type="pmid">37432055</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hsr270448-cit-0005">
<collab collab-type="authors">EFSA Panel on Dietetic Products, N.a.A</collab>
., &#x0201c;<article-title>Scientific Opinion on the Suitability of Goat Milk Protein as a Source of Protein in Infant Formulae and in Follow&#x02010;On Formulae</article-title>,&#x0201d; <source>EFSA Journal</source>
<volume>10</volume>, no. <issue>3</issue> (<year>2012</year>): <fpage>2603</fpage>.</mixed-citation></ref><ref id="hsr270448-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="hsr270448-cit-0006">FDA, <article-title>GRAS Notice 644</article-title>. <year>2017</year>.</mixed-citation></ref><ref id="hsr270448-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hsr270448-cit-0007">
<string-name>
<given-names>K.</given-names>
<surname>Bajerova</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Salvatore</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Dupont</surname>
</string-name>, et al., &#x0201c;<article-title>The Cow's Milk&#x02010;Related Symptom Score (Comiss(&#x02122;)): A Useful Awareness Tool</article-title>,&#x0201d; <source>Nutrients</source>
<volume>14</volume>, no. <issue>10</issue> (<year>2022</year>): <fpage>2059</fpage>.<pub-id pub-id-type="pmid">35631201</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="hsr270448-cit-0008">
<string-name>
<given-names>Y.</given-names>
<surname>Vandenplas</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Dupont</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Eigenmann</surname>
</string-name>, et al., &#x0201c;<article-title>A Workshop Report on the Development of the Cow's Milk&#x02010;Related Symptom Score Awareness Tool for Young Children</article-title>,&#x0201d; <source>Acta Paediatrica</source>
<volume>104</volume>, no. <issue>4</issue> (<year>2015</year>): <fpage>334</fpage>&#x02013;<lpage>339</lpage>.<pub-id pub-id-type="pmid">25557474</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="hsr270448-cit-0009">
<string-name>
<given-names>Y.</given-names>
<surname>Vandenplas</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Bajerova</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Dupont</surname>
</string-name>, et al., &#x0201c;<article-title>The Cow's Milk Related Symptom Score: The 2022 Update</article-title>,&#x0201d; <source>Nutrients</source>
<volume>14</volume>, no. <issue>13</issue> (<year>2022</year>): <fpage>2682</fpage>.<pub-id pub-id-type="pmid">35807862</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hsr270448-cit-0010">
<string-name>
<given-names>D. D.</given-names>
<surname>Infante</surname>
</string-name>, <string-name>
<given-names>C. G.</given-names>
<surname>Prosser</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Tormo</surname>
</string-name>, &#x0201c;<article-title>Constipated Patients Fed Goat Milk Protein Formula: A Case Series Study</article-title>,&#x0201d; <source>Journal of Nutrition and Health Sciences</source>
<volume>5</volume>, no. <issue>2</issue> (<year>2018</year>): <fpage>1</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="hsr270448-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hsr270448-cit-0011">
<string-name>
<given-names>Y.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>E. Y.</given-names>
<surname>Chang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Kim</surname>
</string-name>, et al., &#x0201c;<article-title>Association of Infant Feeding Practices in the General Population With Infant Growth and Stool Characteristics</article-title>,&#x0201d; <source>Nutrition Research and Practice</source>
<volume>5</volume>, no. <issue>4</issue> (<year>2011</year>): <fpage>308</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="pmid">21994525</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hsr270448-cit-0012">
<string-name>
<given-names>C.</given-names>
<surname>Grant</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Rotherham</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sharpe</surname>
</string-name>, et al., &#x0201c;<article-title>Randomized, Double&#x02010;Blind Comparison of Growth in Infants Receiving Goat Milk Formula Versus Cow Milk Infant Formula</article-title>,&#x0201d; <source>Journal of Paediatrics and Child Health</source>
<volume>41</volume>, no. <issue>11</issue> (<year>2005</year>): <fpage>564</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">16398838</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hsr270448-cit-0013">
<string-name>
<given-names>A.</given-names>
<surname>Salsberg</surname>
</string-name>, &#x0201c;<article-title>Goat Milk Toddler Formula Reduces Symptoms Associated With Cow Milk Consumption</article-title>,&#x0201d; <source>Journal of the Academy of Nutrition and Dietetics</source>
<volume>116</volume> (<year>2016</year>): <fpage>A100</fpage>.</mixed-citation></ref><ref id="hsr270448-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hsr270448-cit-0014">
<string-name>
<given-names>T.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Woudstra</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Panzer</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Haandrikman</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Verkade</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>van Lee</surname>
</string-name>, &#x0201c;<article-title>Goat Milk Based Infant Formula in Newborns: A Double&#x02010;Blind Randomized Controlled Trial on Growth and Safety</article-title>,&#x0201d; <source>Journal of Pediatric Gastroenterology &#x00026; Nutrition</source>
<volume>75</volume>, no. <issue>2</issue> (<year>2022</year>): <fpage>215</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">35666856</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="hsr270448-cit-0015">
<string-name>
<given-names>M.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Dai</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>Comparison of Growth and Nutritional Status in Infants Receiving Goat Milk&#x02010;Based Formula and Cow Milk&#x02010;Based Formula: A Randomized, Double&#x02010;Blind Study</article-title>,&#x0201d; <source>Food &#x00026; Nutrition Research</source>
<volume>59</volume> (<year>2015</year>): <elocation-id>28613</elocation-id>.<pub-id pub-id-type="pmid">26652603</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hsr270448-cit-0016">
<string-name>
<given-names>Y.</given-names>
<surname>Vandenplas</surname>
</string-name>, <string-name>
<given-names>E. D.</given-names>
<surname>Greef</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Veereman</surname>
</string-name>, &#x0201c;<article-title>Prebiotics in Infant Formula</article-title>,&#x0201d; <source>Gut Microbes</source>
<volume>5</volume>, no. <issue>6</issue> (<year>2014</year>): <fpage>681</fpage>&#x02013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">25535999</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hsr270448-cit-0017">
<string-name>
<given-names>K.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Xie</surname>
</string-name>, et al., &#x0201c;<article-title>Efficacy of Bifidobacterium Animalis Subsp. Lactis, BB&#x02010;12(&#x000ae;) on Infant Colic &#x02010; A Randomised, Double&#x02010;Blinded, Placebo&#x02010;Controlled Study</article-title>,&#x0201d; <source>Beneficial Microbes</source>
<volume>12</volume>, no. <issue>6</issue> (<year>2021</year>): <fpage>531</fpage>&#x02013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">34550055</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="hsr270448-cit-0018">
<string-name>
<given-names>T.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Rombouts</surname>
</string-name>, <string-name>
<given-names>A. W. C.</given-names>
<surname>Einerhand</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Hotrum</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>van de Velde</surname>
</string-name>, &#x0201c;<article-title>Gastric Protein Digestion of Goat and Cow Milk Infant Formula and Human Milk Under Simulated Infant Conditions</article-title>,&#x0201d; <source>International Journal of Food Sciences and Nutrition</source>
<volume>73</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>28</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">33957845</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hsr270448-cit-0019">
<string-name>
<given-names>A.</given-names>
<surname>Ye</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Cui</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Carpenter</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Prosser</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Singh</surname>
</string-name>, &#x0201c;<article-title>Dynamic in Vitro Gastric Digestion of Infant Formulae Made With Goat Milk and Cow Milk: Influence of Protein Composition</article-title>,&#x0201d; <source>International Dairy Journal</source>
<volume>97</volume> (<year>2019</year>): <fpage>76</fpage>&#x02013;<lpage>85</lpage>.</mixed-citation></ref><ref id="hsr270448-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hsr270448-cit-0020">
<string-name>
<given-names>A.</given-names>
<surname>Maathuis</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Havenaar</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>He</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Bellmann</surname>
</string-name>, &#x0201c;<article-title>Protein Digestion and Quality of Goat and Cow Milk Infant Formula and Human Milk Under Simulated Infant Conditions</article-title>,&#x0201d; <source>Journal of Pediatric Gastroenterology &#x00026; Nutrition</source>
<volume>65</volume>, no. <issue>6</issue> (<year>2017</year>): <fpage>661</fpage>&#x02013;<lpage>666</lpage>.<pub-id pub-id-type="pmid">28968291</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hsr270448-cit-0021">
<string-name>
<given-names>S.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xie</surname>
</string-name>, et al., &#x0201c;<article-title>Gold Standard for Nutrition: A Review of Human Milk Oligosaccharide and its Effects on Infant Gut Microbiota</article-title>,&#x0201d; <source>Microbial Cell Factories</source>
<volume>20</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>108</fpage>.<pub-id pub-id-type="pmid">34049536</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hsr270448-cit-0022">
<string-name>
<given-names>S. H.</given-names>
<surname>Cochrane</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Leslie</surname>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>O'Hara</surname>
</string-name>, &#x0201c;<article-title>Parental Education and Child Health: Intracountry Evidence</article-title>,&#x0201d; <source>Health Policy and Education</source>
<volume>2</volume>, no. <issue>3&#x02013;4</issue> (<year>1982</year>): <fpage>213</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">10298649</pub-id>
</mixed-citation></ref><ref id="hsr270448-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hsr270448-cit-0023">
<string-name>
<given-names>Y.</given-names>
<surname>Vandenplas</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Carvajal</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Peeters</surname>
</string-name>, et al., &#x0201c;<article-title>The Cow's Milk&#x02010;Related Symptom Score (Comiss(Tm)): Health Care Professional and Parent and Day&#x02010;To&#x02010;Day Variability</article-title>,&#x0201d; <source>Nutrients</source>
<volume>12</volume>, no. <issue>2</issue> (<year>2020</year>): <fpage>438</fpage>.<pub-id pub-id-type="pmid">32050456</pub-id>
</mixed-citation></ref></ref-list></back></article>